Shopping Cart
Remove All
Your shopping cart is currently empty
HDAC-IN-72 (compound 7j), a potent inhibitor of HDAC1 (IC 50 =0.65 ± 0.07 μM), HDAC2 (IC 50 =0.78 ± 0.02 μM), and HDAC3 (IC 50 =1.70 ± 0.1 μM), exhibits significant antiproliferative properties. This compound is employed in breast cancer research [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 4-6 weeks | 4-6 weeks | |
| 50 mg | $1,980 | 4-6 weeks | 4-6 weeks | |
| 100 mg | $2,500 | 4-6 weeks | 4-6 weeks |
| Description | HDAC-IN-72 (compound 7j), a potent inhibitor of HDAC1 (IC 50 =0.65 ± 0.07 μM), HDAC2 (IC 50 =0.78 ± 0.02 μM), and HDAC3 (IC 50 =1.70 ± 0.1 μM), exhibits significant antiproliferative properties. This compound is employed in breast cancer research [1]. |
| Targets&IC50 | HDAC3:1.70 μM, HDAC1:0.65 μM, HDAC2:0.78 μM |
| In vitro | HDAC-IN-72 (0.1-50 μM, 48 h) exhibits notable antiproliferative activity against the breast cancer cell lines MCF-7 (IC 50 = 0.83 ± 1.41 μM) and T47D (IC 50 = 1.4 ± 1.85 μM) [1]. |
| Molecular Weight | 359.42 |
| Formula | C22H21N3O2 |
| Cas No. | 763066-77-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.